<?xml version="1.0" encoding="UTF-8"?>
<TEI xml:space="preserve" xmlns="http://www.tei-c.org/ns/1.0" 
xmlns:xsi="http://www.w3.org/2001/XMLSchema-instance" 
xsi:schemaLocation="http://www.tei-c.org/ns/1.0 https://raw.githubusercontent.com/kermitt2/grobid/master/grobid-home/schemas/xsd/Grobid.xsd"
 xmlns:xlink="http://www.w3.org/1999/xlink">
	<teiHeader xml:lang="en">
		<fileDesc>
			<titleStmt>
				<title level="a" type="main">EUROPEAN SYNCHROTRON RADIATION FACILITY</title>
			</titleStmt>
			<publicationStmt>
				<publisher/>
				<availability  status="unknown">
					<licence/>
				</availability>
				<date type="published" when="2010-10-04">October 4 th 2010</date>
			</publicationStmt>
			<sourceDesc>
				<biblStruct>
					<analytic>
						<author>
							<persName><forename type="first">Helene</forename><surname>Elleaume</surname></persName>
							<email>h.elleaume@esrf.fr</email>
							<affiliation key="aff1">
								<orgName type="institution">ADAM Jean Francois Phone +33</orgName>
							</affiliation>
							<affiliation key="aff2">
								<orgName type="department">ESTEVE Francois Phone +33</orgName>
							</affiliation>
							<affiliation key="aff3">
								<orgName type="department">DEMAN Pierre Phone +33</orgName>
							</affiliation>
							<affiliation key="aff4">
								<orgName type="department">Institute of Pathology</orgName>
								<orgName type="laboratory" key="lab1">RAVANAT Jean Luc CEA Grenoble</orgName>
								<orgName type="laboratory" key="lab2">Laboratory</orgName>
								<orgName type="institution">University of Bern</orgName>
								<address>
									<addrLine>Murtenstrasse 31</addrLine>
									<postBox>P.O. 62</postBox>
									<postCode>CH-3010</postCode>
									<settlement>BERN</settlement>
									<country key="CH">Switzerland</country>
								</address>
							</affiliation>
						</author>
						<author>
							<persName><roleName>Prof</roleName><forename type="first">Jean</forename><forename type="middle">A</forename><surname>Laissue</surname></persName>
							<email>laissue@pathology.unibe.ch</email>
						</author>
						<author>
							<persName><surname>Phone</surname></persName>
						</author>
						<author>
							<affiliation key="aff0">
								<orgName type="institution">INSERM</orgName>
								<address>
									<addrLine>U836 equipe 6 GIN</addrLine>
									<settlement>Grenoble</settlement>
									<country key="FR">France</country>
								</address>
							</affiliation>
						</author>
						<author>
							<affiliation key="aff5">
								<orgName type="department">Medical Department Upton</orgName>
								<orgName type="laboratory">Laboratory Brookhaven National Laboratory</orgName>
								<address>
									<addrLine>Bld 490 New york</addrLine>
									<postCode>11973-5000</postCode>
									<country key="US">USA</country>
								</address>
							</affiliation>
						</author>
						<author>
							<affiliation key="aff6">
								<orgName type="department">Dept of Pharmacology</orgName>
								<orgName type="laboratory">Laboratory</orgName>
								<orgName type="institution">University of Connecticut Health Center</orgName>
								<address>
									<addrLine>263 Farmington Ave. Farmington</addrLine>
									<postCode>06030</postCode>
									<region>CT</region>
									<country key="US">USA</country>
								</address>
							</affiliation>
						</author>
						<author>
							<affiliation key="aff7">
								<orgName type="laboratory">Name PhD HAINFELD James Phone +1</orgName>
								<orgName type="institution">Laboratory NANOPROBES</orgName>
								<address>
									<addrLine>95 Horseblock Road Yaphank</addrLine>
									<postCode>11980-9710</postCode>
									<region>NY</region>
									<country>USA -</country>
								</address>
							</affiliation>
						</author>
						<title level="a" type="main">EUROPEAN SYNCHROTRON RADIATION FACILITY</title>
					</analytic>
					<monogr>
						<imprint>
							<date type="published" when="2010-10-04">October 4 th 2010</date>
						</imprint>
					</monogr>
					<idno type="MD5">E96B0586DA1F31B65097CA012F4B6DE4</idno>
					<note type="submission">from: September 17th 2009 to: September 20 th 2009</note>
				</biblStruct>
			</sourceDesc>
		</fileDesc>
		<encodingDesc>
			<appInfo>
				<application version="0.8.2" ident="GROBID" when="2025-05-24T00:46+0000">
					<desc>GROBID - A machine learning software for extracting information from scholarly documents</desc>
					<label type="revision">unknown</label>
					<label type="parameters">startPage=-1, endPage=-1, consolidateCitations=1, consolidateHeader=1, consolidateFunders=0, includeRawAffiliations=false, includeRawCitations=true, includeRawCopyrights=false, generateTeiIds=false, generateTeiCoordinates=[], flavor=null</label>
					<ref target="https://github.com/kermitt2/grobid"/>
				</application>
			</appInfo>
		</encodingDesc>
		<profileDesc>
			<abstract/>
		</profileDesc>
	</teiHeader>
	<text xml:lang="en">
		<body/>
		<back>
			<div type="annex">
<div xmlns="http://www.tei-c.org/ns/1.0"><head>Report:</head><p>Aims of the experiment and scientific background: The purpose of this study was to determine the dose-enhancement factor on F98 cells at 50 keV using 15 nmdiameter and 1.9 nm-diameter gold nanoparticles (AuNPs).</p><p>Cell survival studies were performed in the first part of the proposed experiment, in the second part, goldenhanced Synchrotron Stereotactic Radiotherapy was performed on the F98 rodent glioma model, after intratumoral injection by convection-enhanced delivery methods of 15 nm AuNPs. These results could be compared with the results obtained in the previous in vivo study with smaller AuNPs (proposal MD-355).</p></div>
<div xmlns="http://www.tei-c.org/ns/1.0"><head>In vitro results (17-20 September 2009):</head><p>The experiments were carried on F98 glioma cells. The cells were irradiated at 50 keV in media containing or not gold nanoparticles at a gold concentration of 10 mg/mL. A dose enhancement factor was observed for both the AuNPs of 1.9 nm and 15 nm (DEF=1.9 and 1.4 ,respectively). but a DEF more significant was noticed for the 15 nm AuNPs.</p><p>In vivo results (25-28 November 2009):</p><p>A preliminary study was carried out in February 2009, using intracerebral nanoparticles delivery in association with synchrotron stereotactic radiotherapy for the treatment of F98 glioma bearing rats (MD355). An important toxicity was observed with these gold nanoparticles. The present study was performed with 15 nm gold nanoparticles. For all irradiated groups, the irradiation was performed on day 14, following the irradiation set-up described in the previous study <ref type="bibr" target="#b0">[1]</ref>. The gold nanoparticles were injected into the tumor by convection-enhanced delivery methods few minutes before irradiation, as described previously <ref type="bibr" target="#b1">[2,</ref><ref type="bibr" target="#b2">3]</ref>.</p><p>The rats were divided into 6 experimental groups: Group 1 : "untreated animals", Group 2 : "irradiation alone 15 Gy delivered in a single fraction", Group 3 : "gold alone 125 µg/ 5 µl", Group 4 : "gold alone 250 µg/ 5 µl", Group 5 : "gold alone 125 µg/ 5 µl + irradiation " Group 6 : "gold alone 250 µg/ 5 µl + irradiation ".</p><p>No toxicity was observed after intracerebral injection of these AuNPs. An increase of median survival life span was observed for the rats treated with gold and irradiation in comparison with the "irradiation alone group". The median survival time of group 2 was: 35 days, Group 5: 37 days, Group 6: 41 days. The differences were however not significant (p&gt;0.05).</p></div>
<div xmlns="http://www.tei-c.org/ns/1.0"><head>Conclusions:</head><p>These preliminary results demonstrate that dose-enhancement can be obtained in presence of gold nanoparticles, both in vitro and in vivo. However, this method will require further studies to obtain in vivo a more substantial survival improvement. The results of these experiement will soon be published and are part of Laure Bobyk's PHD thesis (Grenoble University -November 10 th 2010).</p></div>			</div>
			<div type="references">

				<listBibl>

<biblStruct xml:id="b0">
	<analytic>
		<title level="a" type="main">Synchrotron radiation therapy of malignant brain glioma loaded with an iodinated contrast agent: First trial on rats bearing F98 gliomas</title>
		<author>
			<persName><forename type="first">Jean-François</forename><surname>Adam</surname></persName>
		</author>
		<author>
			<persName><forename type="first">Hélène</forename><surname>Elleaume</surname></persName>
		</author>
		<author>
			<persName><forename type="first">Aurélie</forename><surname>Joubert</surname></persName>
		</author>
		<author>
			<persName><forename type="first">Marie-Claude</forename><surname>Biston</surname></persName>
		</author>
		<author>
			<persName><forename type="first">Anne-Marie</forename><surname>Charvet</surname></persName>
		</author>
		<author>
			<persName><forename type="first">Jacques</forename><surname>Balosso</surname></persName>
		</author>
		<author>
			<persName><forename type="first">Jean-François</forename><surname>Le Bas</surname></persName>
		</author>
		<author>
			<persName><forename type="first">François</forename><surname>Estève</surname></persName>
		</author>
		<idno type="DOI">10.1016/j.ijrobp.2003.07.007</idno>
	</analytic>
	<monogr>
		<title level="j">International Journal of Radiation Oncology*Biology*Physics</title>
		<title level="j" type="abbrev">International Journal of Radiation Oncology*Biology*Physics</title>
		<idno type="ISSN">0360-3016</idno>
		<imprint>
			<biblScope unit="volume">57</biblScope>
			<biblScope unit="issue">5</biblScope>
			<biblScope unit="page" from="1413" to="1426" />
			<date type="published" when="2003-12">2003</date>
			<publisher>Elsevier BV</publisher>
		</imprint>
	</monogr>
	<note type="raw_reference">Adam JF, Elleaume H, Joubert A, Biston MC, Charvet AM, Balosso J, Le Bas JF, Esteve F: Synchrotron radiation therapy of malignant brain glioma loaded with an iodinated contrast agent: first trial on rats bearing F98 gliomas. Int J Radiat Oncol Biol Phys 57: 1413-1426, 2003</note>
</biblStruct>

<biblStruct xml:id="b1">
	<analytic>
		<title level="a" type="main">Enhanced Survival and Cure of F98 Glioma–Bearing Rats following Intracerebral Delivery of Carboplatin in Combination with Photon Irradiation</title>
		<author>
			<persName><forename type="first">Julia</forename><surname>Rousseau</surname></persName>
		</author>
		<author>
			<persName><forename type="first">Caroline</forename><surname>Boudou</surname></persName>
		</author>
		<author>
			<persName><forename type="first">Rolf</forename><forename type="middle">F</forename><surname>Barth</surname></persName>
		</author>
		<author>
			<persName><forename type="first">Jacques</forename><surname>Balosso</surname></persName>
		</author>
		<author>
			<persName><forename type="first">François</forename><surname>Estève</surname></persName>
		</author>
		<author>
			<persName><forename type="first">Hélène</forename><surname>Elleaume</surname></persName>
		</author>
		<idno type="DOI">10.1158/1078-0432.ccr-07-1002</idno>
	</analytic>
	<monogr>
		<title level="j">Clinical Cancer Research</title>
		<idno type="ISSN">1078-0432</idno>
		<idno type="ISSNe">1557-3265</idno>
		<imprint>
			<biblScope unit="volume">13</biblScope>
			<biblScope unit="issue">17</biblScope>
			<biblScope unit="page" from="5195" to="5201" />
			<date type="published" when="2007-09-01">2007</date>
			<publisher>American Association for Cancer Research (AACR)</publisher>
		</imprint>
	</monogr>
	<note type="raw_reference">Rousseau J, Boudou C, Barth RF, Balosso J, Esteve F, Elleaume H: Enhanced survival and cure of F98 glioma-bearing rats following intracerebral delivery of carboplatin in combination with photon irradiation. Clin Cancer Res 13: 5195-5201, 2007</note>
</biblStruct>

<biblStruct xml:id="b2">
	<analytic>
		<title level="a" type="main">Convection-Enhanced Delivery of an Iodine Tracer Into Rat Brain for Synchrotron Stereotactic Radiotherapy</title>
		<author>
			<persName><forename type="first">Julia</forename><surname>Rousseau</surname></persName>
		</author>
		<author>
			<persName><forename type="first">Caroline</forename><surname>Boudou</surname></persName>
		</author>
		<author>
			<persName><forename type="first">François</forename><surname>Estève</surname></persName>
		</author>
		<author>
			<persName><forename type="first">Hélène</forename><surname>Elleaume</surname></persName>
		</author>
		<idno type="DOI">10.1016/j.ijrobp.2007.01.065</idno>
	</analytic>
	<monogr>
		<title level="j">International Journal of Radiation Oncology*Biology*Physics</title>
		<title level="j" type="abbrev">International Journal of Radiation Oncology*Biology*Physics</title>
		<idno type="ISSN">0360-3016</idno>
		<imprint>
			<biblScope unit="volume">68</biblScope>
			<biblScope unit="issue">3</biblScope>
			<biblScope unit="page" from="943" to="951" />
			<date type="published" when="2007-07">2007</date>
			<publisher>Elsevier BV</publisher>
		</imprint>
	</monogr>
	<note type="raw_reference">Rousseau J, Boudou C, Esteve F, Elleaume H: Convection-enhanced delivery of an iodine tracer into rat brain for synchrotron stereotactic radiotherapy. Int J Radiat Oncol Biol Phys 68: 943-951, 2007</note>
</biblStruct>

				</listBibl>
			</div>
		</back>
	</text>
</TEI>
